» Articles » PMID: 8434391

Specific Unresponsiveness in Rats with Prolonged Cardiac Allograft Survival After Treatment with Cyclosporine. VI. In Vitro Alloreactivity of T Cell Subsets from Rats with Long-surviving Allografts

Overview
Journal Transplantation
Specialty General Surgery
Date 1993 Feb 1
PMID 8434391
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

DA rats treated with a short course of cyclosporine develop specific unresponsiveness to RT1-incompatible PVG donor heart allografts. CD4+ cells, not CD8+ cells, transfer unresponsiveness to irradiated rats. However, host-derived CD8+ cells are important in reestablishing unresponsiveness. In this study, unfractionated lymphoid cells and W3/25+ (CD4+) cells from CsA-treated rats with long-surviving PVG allografts demonstrated normal alloreactivity to PVG alloantigen in the mixed lymphocyte culture and failed to suppress the proliferative response of naive W3/25+ cells to donor-specific alloantigen. MRC OX8+ (CD8+) cells did not proliferate. Sera from CsA-treated rats had no effect on the MLC reactivity of cells from CsA-treated rats, suggesting that blocking or antiidiotypic antibodies did not diminish alloreactivity. IL-2 production by W3/25+ cells from CsA-treated rats was similar to that by W3/25+ cells from naive rats. Specific cytotoxic T cells to PVG were generated in MLC, and the frequency of precursor cytotoxic lymphocytes in CsA-treated rats was similar to that in naive DA rats. In an in vitro assay testing response to idiotype, neither W3/25+ or MRC OX8+ cells from unresponsive rats proliferated. As CD4+ cells from CsA-treated rats lose their capacity to adoptively transfer specific unresponsiveness unless maintained in a cytokine-rich supernatant, all in vitro assays were performed with and without added cytokines, but no change in reactivity consistent with suppression was observed in any assay. CD4+ suppressor cells had no effect on conventional in vitro assays of alloreactivity, preventing the detection of the unresponsiveness in vitro.

Citing Articles

CD4CD25 T regulatory cells in renal transplantation.

Cheung J, Zahorowska B, Suranyi M, Wong J, Diep J, Spicer S Front Immunol. 2022; 13:1017683.

PMID: 36426347 PMC: 9681496. DOI: 10.3389/fimmu.2022.1017683.


Transplant Tolerance, Not Only Clonal Deletion.

Hall B, Verma N, Tran G, Hodgkinson S Front Immunol. 2022; 13:810798.

PMID: 35529847 PMC: 9069565. DOI: 10.3389/fimmu.2022.810798.


Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4CD25 Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor.

Hall B, Hall R, Tran G, Robinson C, Wilcox P, Rakesh P Front Immunol. 2021; 12:714838.

PMID: 34912327 PMC: 8667344. DOI: 10.3389/fimmu.2021.714838.


Regulatory T Cell Extracellular Vesicles Modify T-Effector Cell Cytokine Production and Protect Against Human Skin Allograft Damage.

Tung S, Fanelli G, Matthews R, Bazoer J, Letizia M, Vizcay-Barrena G Front Cell Dev Biol. 2020; 8:317.

PMID: 32509778 PMC: 7251034. DOI: 10.3389/fcell.2020.00317.


Alloactivation of Naïve CD4CD8CD25T Regulatory Cells: Expression of CD8α Identifies Potent Suppressor Cells That Can Promote Transplant Tolerance Induction.

Verma N, Robinson C, Carter N, Wilcox P, Tran G, Wang C Front Immunol. 2019; 10:2397.

PMID: 31681288 PMC: 6802415. DOI: 10.3389/fimmu.2019.02397.